News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases
Shankar Siva/iconcancercentre.com.au
May 11, 2025, 15:32

Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

” New in Journal of Clinical Oncology – ROBOMET
SABR vs standard radiotherapy for painful bone mets.
  • Pain relief at 1 month:
  • SABR (20 Gy single dose): 37% complete response
  • versus (8 Gy): 25% complete response
  • at 3-months withSABR: 54% vs 31%, p= .048″

Title: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial

Authors: Carole Mercier, Charlotte Billiet, Katrien Vandecasteele, Geert De Kerf, Michaël Claessens, Steven Van Laere, Peter Vermeulen, Luc Dirix, Yolande Lievens, Dirk Verellen, Piet Dirix

You can read the Full Article on Journal of Clinical Oncology

Shankar Siva

More posts featuring Shankar Siva.

bone metastases cancer Carole Mercier Charlotte Billiet Conventional Radiotherapy Dirk Verellen Geert De Kerf Journal of Clinical Oncology Katrien Vandecasteele Luc Dirix Michaël Claessens OncoDaily Oncology Peter Vermeulen Piet Dirix radiotherapy ROBOMET Shankar Siva Stereotactic Radiotherapy Steven Van Laere Yolande Lievens
Special Coverage
Insight
Jun 24, 2025, 16:35
Jill Feldman: Hope for EGFR+ NSCLC after Prior EGFR-directed Therapy and Platinum-based Chemotherapy
Oncolibrary
Jun 24, 2025, 15:53
Bone Cancer Treatment Success Rate: What Patients Should Know
Oncolibrary
Jun 24, 2025, 13:21
Natural Ways to Prevent Hair Loss During Chemotherapy: What Actually Works?
Stories
Jun 24, 2025, 11:46
Survivorship and Beyond: Sally Wolf Reflects on 9 Years After Chemotherapy
Blog
Jun 24, 2025, 11:38
Michael Methner: A Thriving Survivor Thanks to Progress in Cancer Research - AACR
Blog
Jun 24, 2025, 11:11
Ashok Sebastian Komaranchath: Team BCI Muscat is Bringing the Best in Cancer Care to Oman
Blog
Jun 24, 2025, 11:04
Hillary Andrews: Excited to Share That Theresa's Research Foundation's Manuscript about MARP was Published in npj Breast Cancer
Blog
Jun 24, 2025, 10:52
Miloš Grujić Shared Highlights from the 2025 ESO Masterclass in Clinical Oncology - Summer Edition
Blog
Jun 24, 2025, 10:40
Shahrin Ahmed: Gain Respect for Yourself and Build a Future That Benefits Your Family
Career
Jun 24, 2025, 10:40
Aaron Scott was Appointed Director of the Early Therapeutics Program at the University of Arizona Comprehensive Cancer Center
Insight
Jun 24, 2025, 10:34
Estela Rodriguez: FDA Grants Accelerated Approval to Dato-Dxd for Previously Treated EGFR+ NSCLC
Career
Jun 24, 2025, 10:32
Mark Everard Has Been Appointed Chair of World Child Cancer Ambassadors Group